NO992107L - FremgangsmÕte for pÕvisning av forbindelser som modulerer effekten av fett (OB) proteinet - Google Patents

FremgangsmÕte for pÕvisning av forbindelser som modulerer effekten av fett (OB) proteinet

Info

Publication number: NO992107L
Authority: NO; Norway
Prior art keywords: cell line; protein; derived cell; compound; response element
Prior art date: 1996-11-01

Application number

NO992107A

Other languages

English (en)

Norwegian (no)

Other versions

NO992107D0 (no

Inventor

Lee James Beeley

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-11-01

Filing date

1999-04-30

Publication date

1999-06-30

1996-11-01 Priority claimed from GBGB9622867.1A external-priority patent/GB9622867D0/en

1996-11-01 Priority claimed from GBGB9622851.5A external-priority patent/GB9622851D0/en

1996-11-01 Priority claimed from GBGB9622848.1A external-priority patent/GB9622848D0/en

1996-11-01 Priority claimed from GBGB9622869.7A external-priority patent/GB9622869D0/en

1996-11-01 Priority claimed from GBGB9622850.7A external-priority patent/GB9622850D0/en

1996-11-01 Priority claimed from GBGB9622870.5A external-priority patent/GB9622870D0/en

1996-11-01 Priority claimed from GBGB9622866.3A external-priority patent/GB9622866D0/en

1996-11-01 Priority claimed from GBGB9622868.9A external-priority patent/GB9622868D0/en

1996-11-01 Priority claimed from GBGB9622849.9A external-priority patent/GB9622849D0/en

1996-11-01 Priority claimed from GBGB9622847.3A external-priority patent/GB9622847D0/en

1996-11-01 Priority claimed from GBGB9622865.5A external-priority patent/GB9622865D0/en

1999-04-30 Publication of NO992107D0 publication Critical patent/NO992107D0/no

1999-04-30 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

1999-06-30 Publication of NO992107L publication Critical patent/NO992107L/no

Links

150000001875 compounds Chemical class 0.000 title abstract 6
230000000694 effects Effects 0.000 title abstract 3
238000000034 method Methods 0.000 title abstract 2
102000004169 proteins and genes Human genes 0.000 title 1
108090000623 proteins and genes Proteins 0.000 title 1
210000004027 cell Anatomy 0.000 abstract 13
102000016267 Leptin Human genes 0.000 abstract 9
108010092277 Leptin Proteins 0.000 abstract 9
108091027981 Response element Proteins 0.000 abstract 5
101000617830 Homo sapiens Sterol O-acyltransferase 1 Proteins 0.000 abstract 4
102100021993 Sterol O-acyltransferase 1 Human genes 0.000 abstract 4
101000697584 Streptomyces lavendulae Streptothricin acetyltransferase Proteins 0.000 abstract 4
230000001766 physiological effect Effects 0.000 abstract 3
108700008625 Reporter Genes Proteins 0.000 abstract 2
101710140204 Signal transducer and transcription activator Proteins 0.000 abstract 1
108050007918 Transcription factor STAT Proteins 0.000 abstract 1
102000000887 Transcription factor STAT Human genes 0.000 abstract 1
210000003016 hypothalamus Anatomy 0.000 abstract 1
210000004185 liver Anatomy 0.000 abstract 1
230000002611 ovarian Effects 0.000 abstract 1
208000028591 pheochromocytoma Diseases 0.000 abstract 1
229920001184 polypeptide Polymers 0.000 abstract 1
210000000229 preadipocyte Anatomy 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1
102000004196 processed proteins & peptides Human genes 0.000 abstract 1
210000002027 skeletal muscle Anatomy 0.000 abstract 1
230000000638 stimulation Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Immunology (AREA)
General Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Analytical Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Endocrinology (AREA)
Physics & Mathematics (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Cell Biology (AREA)
Child & Adolescent Psychology (AREA)
Obesity (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Investigating Or Analysing Biological Materials (AREA)

NO992107A 1996-11-01 1999-04-30 FremgangsmÕte for pÕvisning av forbindelser som modulerer effekten av fett (OB) proteinet NO992107L (no)

Applications Claiming Priority (12)

Application Number	Priority Date	Filing Date	Title
GBGB9622869.7A GB9622869D0 (en)	1996-11-01	1996-11-01	Novel method
GBGB9622850.7A GB9622850D0 (en)	1996-11-01	1996-11-01	Novel method
GBGB9622870.5A GB9622870D0 (en)	1996-11-01	1996-11-01	Novel method
GBGB9622867.1A GB9622867D0 (en)	1996-11-01	1996-11-01	Novel method
GBGB9622868.9A GB9622868D0 (en)	1996-11-01	1996-11-01	Novel method
GBGB9622866.3A GB9622866D0 (en)	1996-11-01	1996-11-01	Novel method
GBGB9622847.3A GB9622847D0 (en)	1996-11-01	1996-11-01	Novel method
GBGB9622865.5A GB9622865D0 (en)	1996-11-01	1996-11-01	Novel method
GBGB9622849.9A GB9622849D0 (en)	1996-11-01	1996-11-01	Novel method
GBGB9622851.5A GB9622851D0 (en)	1996-11-01	1996-11-01	Novel method
GBGB9622848.1A GB9622848D0 (en)	1996-11-01	1996-11-01	Novel method
PCT/GB1997/002988 WO1998020158A1 (en)	1996-11-01	1997-10-30	Method for the detection of compounds that modulate the effects of the obese (ob) protein

Publications (2)

Publication Number	Publication Date
NO992107D0 NO992107D0 (no)	1999-04-30
NO992107L true NO992107L (no)	1999-06-30

Family

ID=27581686

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO992107A NO992107L (no)	1996-11-01	1999-04-30	FremgangsmÕte for pÕvisning av forbindelser som modulerer effekten av fett (OB) proteinet

Country Status (13)

Country	Link
EP (1)	EP0951564A1 (cs)
JP (1)	JP2001503982A (cs)
KR (1)	KR20000053007A (cs)
AR (1)	AR010262A1 (cs)
AU (1)	AU4789297A (cs)
CA (1)	CA2270431A1 (cs)
CZ (1)	CZ149999A3 (cs)
IL (1)	IL129685A0 (cs)
NO (1)	NO992107L (cs)
NZ (1)	NZ335489A (cs)
PL (1)	PL333187A1 (cs)
TR (1)	TR199900963T2 (cs)
WO (1)	WO1998020158A1 (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1293533B1 (it) *	1997-07-14	1999-03-01	Angeletti P Ist Richerche Bio	Metodo per la selezione di molecole in grado di mimare, inibire o potenziare gli effetti della interazione tra leptina e cellule che
GB9814199D0 (en) *	1998-06-30	1998-08-26	Univ Buckingham	Novel method
EP1101112B1 (en)	1998-07-28	2004-10-06	Vlaams Interuniversitair Instituut voor Biotechnologie vzw.	Leptin-mediated gene-induction
GB9828087D0 (en) *	1998-12-18	1999-02-17	Smithkline Beecham Plc	Novel method
EP1283878B1 (en)	2000-05-22	2005-07-27	Vlaams Interuniversitair Instituut voor Biotechnologie vzw.	Receptor-based interaction trap
GB0019327D0 (en) *	2000-08-08	2000-09-27	Buchanan Baillie Hamilton Paul	Slimming system
EP1812038A1 (en)	2004-11-18	2007-08-01	VIB vzw	Fibronectin iii domain as leptin receptor antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2285995A (en) *	1994-04-14	1995-11-10	Ligand Pharmaceuticals Incorporated	Dna spacer regulatory elements responsive to cytokines and methods for their use
US5643748A (en) *	1994-09-14	1997-07-01	Progenitor, Inc.	HU-B1.219, a novel human hematopoietin receptor
AU5524896A (en) *	1995-03-20	1996-10-08	Institut Pasteur De Lille	Modulators of ob gene and screening methods therefor
US5712094A (en) *	1995-03-27	1998-01-27	Ligand Pharmaceuticals, Inc.	Methods for detecting modulators of cytokine action
PL323638A1 (en) *	1995-05-30	1998-04-14	Smithkline Beecham Plc	Method of detecting obesity protein modulating compounds
EP0914611A4 (en) *	1996-04-22	2002-10-16	Merck & Co Inc	TRANSACTIVATION OF LEPTIN

1997
- 1997-10-30 PL PL97333187A patent/PL333187A1/xx unknown
- 1997-10-30 TR TR1999/00963T patent/TR199900963T2/xx unknown
- 1997-10-30 JP JP52112898A patent/JP2001503982A/ja active Pending
- 1997-10-30 NZ NZ335489A patent/NZ335489A/xx unknown
- 1997-10-30 KR KR1019990703890A patent/KR20000053007A/ko not_active Withdrawn
- 1997-10-30 AU AU47892/97A patent/AU4789297A/en not_active Abandoned
- 1997-10-30 EP EP97910545A patent/EP0951564A1/en not_active Withdrawn
- 1997-10-30 WO PCT/GB1997/002988 patent/WO1998020158A1/en not_active Ceased
- 1997-10-30 IL IL12968597A patent/IL129685A0/xx unknown
- 1997-10-30 CZ CZ991499A patent/CZ149999A3/cs unknown
- 1997-10-30 CA CA002270431A patent/CA2270431A1/en not_active Abandoned
- 1997-10-31 AR ARP970105064A patent/AR010262A1/es unknown
1999
- 1999-04-30 NO NO992107A patent/NO992107L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
TR199900963T2 (xx)	1999-08-23
EP0951564A1 (en)	1999-10-27
JP2001503982A (ja)	2001-03-27
KR20000053007A (ko)	2000-08-25
CZ149999A3 (cs)	1999-10-13
NO992107D0 (no)	1999-04-30
WO1998020158A1 (en)	1998-05-14
NZ335489A (en)	2001-01-26
AU4789297A (en)	1998-05-29
PL333187A1 (en)	1999-11-22
CA2270431A1 (en)	1998-05-14
AR010262A1 (es)	2000-06-07
IL129685A0 (en)	2000-02-29

Legal Events

Date	Code	Title	Description
2003-06-30	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NZ323795A (en)	2000-01-28	Isolated nucleic acid molecules encoding AUR-1 (aurora-1) and AUR-2 polypeptides
NO962991L (no)	1996-09-18	Zink-finger-proteinderivater og fremgangsmåter derav
ATE245699T1 (de)	2003-08-15	Rekombinant pgp3, verfahren zu dessen herstellung,und dessen verwendung in der diagnose und therapie
NO865015L (no)	1986-12-11	Fremgangsmaate for utvinning av chitin fra materialer hvor chitin opptrer sammen med, eller i tilknytning til, proteinsubstanser.
DE3779706D1 (de)	1992-07-16	Enzymsensor zur bestimmung von glutaminat-konzentration.
NO992107L (no)	1999-06-30	FremgangsmÕte for pÕvisning av forbindelser som modulerer effekten av fett (OB) proteinet
Ueno et al.	1984	Identification of storage protein receptor and its precursor in the fat body membrane of Sarcophaga peregrina.
ATE69108T1 (de)	1991-11-15	Elektrophoretisches gel hoher aufloesung sowie methode zur abscheidung von serumproteinen.
DE3788828D1 (de)	1994-03-03	Stabilisierte flüssige Enzymzusammensetzung zur Bestimmung von Glucose.
NO975504L (no)	1997-11-28	Fremgangsmåte for påvisning av forbindelser som modulerer virkningene av fettproteinet
ATE207617T1 (de)	2001-11-15	Verfahren zur untersuchung von hausstaub
DK0939769T3 (da)	2006-03-13	Vertebrat-Smoothened-proteiner
DK0788512T3 (da)	1999-10-11	Proinsulinpeptidforbindelser til detektion og behandling af Type I-diabetes
ATE162224T1 (de)	1998-01-15	Crf bindungsproteine
DK0616642T3 (da)	1997-07-07	Hidtil ukendte thrombininhibitoriske proteiner fra landblodigler
FR2509139B1 (fr)	1986-05-16	Isolement de proteine microbienne d'une teneur reduite en acides nucleiques
DasGupta et al.	1979	Purification and characterization of a carboxypeptidase-transpeptidase of Bacillus megaterium acting on the tetrapeptide moiety of the peptidoglycan.
RU94012324A (ru)	1996-07-27	Тест-система для определения белка в моче
NO20006541L (no)	2000-12-21	Fremgangsmåte for påvisning av en forbindelse som etterligner, potensierer eller inhiberer den fysiologiske effekten av leptin
Adams et al.	1978	3-Hydroxyproline content of normal urine.
BURGER et al.	1976	Biological activity of subfractions of human transfer factor
RU95102036A (ru)	1997-03-27	Способ определения спонтанной двигательной активности крыс
DE69836226D1 (de)	2006-11-30	Ifn rezeptor 1 bindende proteine, dafür kodierende dna und verfahren zur regulierung der zellulären antwort auf interferone
COLMAN et al.	1976	Folate radioassay and crude milk binder
Erdos et al.	1972	The Angiotensin 1 Converting Enzyme of the Lung.